| E |
|
Enterobacter aerogenes strains misidentified as Klebsiella pneumoniae and correct identification by sequencing of the QRDR region of the gyrA gene
|
| Agüero J., Conejo M.C., Sáez A., de Cueto M., Martínez-Martínez L., Pascual A. |
| |
|
Enterococcus bacteraemia: striking high mortality
|
| Suppli M., Aabenhus R., Harboe Z., Andersen L., Tvede M., Kirkby N., Jensen J. |
| |
|
Escherichia coli virulence factors in chronic bacterial prostatitis
|
| Vranes J., Antolovic-Pozgain A., Senjug M., Bedenic B. |
| |
|
Early effective treatment of cutaneous infection with Mycobacterium chelonae complex after rapid molecular identification
|
| Hopman J., Langewouters A., Kroese T., Sturm P.D.J. |
| |
|
Early prediction of response during high-dose interferon induction therapy in difficult-to-treat chronic hepatitis C patients
|
| Gelderblom H.C., Zaaijer H.L., Weegink C.J., Dijkgraaf M.G.W., Jansen P.L.M., Beld M.G.H.M., Reesink H.W. |
| |
|
EARSS results: S. pneumoniae resistance related to serogroups?
|
| de Kraker M.E.A., Kahlmeter G., van de Sande-Bruinsma N., Tiemersma E.W., Monen J.C.M., Grundmann H., participants EARSS |
| |
|
Echinococcus cyst of liver and lung in animal models treated by radio-frequency thermal ablation. An ex vivo pilot experimental study
|
| Lamonaca V., Maruzzelli L., Minervini M., Virga N., Di Stefano R., Tagliareni P., Luca A., Sardina G., Vizzini G., Palazzo U., Gridelli B. |
| |
|
ECL-1, a novel plasmid-mediated class A b-lactamase with carbenicillinase characteristics from Escherichia coli
|
| Papagiannitsis C., Loli A., Tzouvelekis L.S., Tzelepi E., Arlet G., Miriagou V. |
| |
|
Effect of Berberis aetnensis C. Presl extract on tissue transglutaminase expression in primary astroglial cell cultures exposed to glutamate
|
| Campisi A., Speciale A., Acquaviva R., Raciti G., Barbagallo I., Puglisi S., Iauk L. |
| |
|
Effect of adequate empiric antibiotic therapy on survival of patients with methicillin-resistant Staphylococcus aureus bacteraemia
|
| Hazzan R., Paul M., Shaked H., Wattad M., Konigsberger H., Rubinovitch B., Leibovici L., Bishara J. |
| |
|
Effect of antibiotics at subMIC concentration on biofilm formation by Streptococcus pyogenes
|
| Baldassarri L., Recchia S., Creti R., Imperi M., Pataracchia M., Orefici G. |
| |
|
Effect of disinfectants and caspofungin against planktonic and sessile cells of Candida spp.
|
| Tobudic S., Kratzer C., Graninger W., Georgopoulos A. |
| |
|
Effect of Fe and glucose on the glycolysis and gluconeogenesis in biofilm-associated Staphylococcus epidermidis
|
| Massonet C., Pintens V., Merckx R., Van Eldere J. |
| |
|
Effect of human albumin physiological concentrations on the in vitro bactericidal activity of daptomycin vs. vancomycin Cmax concentrations against Gram-positive isolates exhibiting the main resistance phenotypes
|
| Cafini F., Aguilar L., González N., Giménez M., Torrico M., Alou L., Sevillano D., Vallejo P., Prieto J. |
| |
|
Effect of intrahepatic hepatitis C virus internal ribosomal entry site activity on the outcome of infection
|
| Motazakker M., McCruden E., Preikschat P., Elliott J., Smith C., Oien K., Spence E., Elliott R., Mills P. |
| |
|
Effect of linezolid and quinupristin/dalfopristin on formation and disruption of Staphylococcus haemolyticus biofilm in vitro
|
| Juda M., Helon P., Malm A. |
| |
|
Effect of moxifloxacin and human beta-defensin 2 on ICAM-1 and cytokines expression in human lung epithelial cell line
|
| Tufano M., Paoletti I., Perfetto B., Iovene M., Tudisco L., Donnarumma G. |
| |
|
Effect of multiple passages of S. typhimurium in the presence of disinfectants on susceptibility to antimicrobials, on persistence in the one-day-old chick model and efflux systems
|
| Bagnall M., Randall L., Coldham N., Karatzas A., Humphrey T., Piddock L., Woodward M. |
| |
|
Effect of polysorbate 80 on oritavancin binding to plastic surfaces – implications for susceptibility testing
|
| Arhin F.F., Sarmiento I., Parr Jr T.J., Moeck G. |
| |
|
Effect of the introduction of the pneumococcal conjugate vaccine on invasive disease produced by Streptococcus pneumoniae
|
| Cercenado E., Cuevas O., Fenoll A., Marin M., Vicioso D., Bouza E. |
| |
|
Effectiveness and tolerability of amoxycillin and azithromycin in treatment of patients with mild-to-moderate community-acquired pneumonias in outpatient settings
|
| Kondratenko A., Bereznyakov I., Pozhar V. |
| |
|
Effectiveness of linezolid in nosocomial and severe community-acquired pneumonia: meta-analysis
|
| Yeniova O., Ascioglu S. |
| |
|
Effectiveness of the antibiotic policy by bed-side consultation
|
| Alzubaidy A.K., Bronsveld W., Steenhoek A., Vlaspolder F., Sloos J.H. |
| |
|
Effectiveness of the lysis centrifugation method isolator 10 system compared to BacT/Alert 3D in detecting bacteraemia
|
| Kharazmi K., Kratzer C., Tucek G., Klimpfinger M., Georgopoulos A. |
| |
|
Effects of cefditoren, cefuroxime, cefaclor and cefixime on the competitive growth of Streptococcus pneumoniae, as a model approach to selection of populations
|
| Cafini F., Torrico M., Gonzalez N., Echevarria O., Sevillano D., Gimenez M.J., Alou L., Aguilar L., Coronel P., Gimeno M., Prieto J. |
| |
|
Effects of education on the importance of blood cultures by an infection control team: experience in two community hospitals, Kyoto, Japan
|
| Saito T., Aoki Y., Matsuoka A., Iinuma Y., Takakura S., Fujiwara N., Kohi F., Noguchi M., Ichiyama S. |
| |
|
Effects of intermittent preventive anti-malarial treatment of infants in a holoendemic area
|
| Kobbe R., Adjei S., Adjei O., May on behalf of the Agona IPTi Trial Team J. |
| |
|
Effects of MG3290, a selective histone deacetylase inhibitor, on azole resistance in Candidaglabrata
|
| Yeung B., Georgopapadakou N. |
| |
|
Effects of vasoactive amines and albumin upon yeast susceptibility to antifungals
|
| Costa-de-Oliveira S., Silva Dias A., Pina-Vaz C., Gonçalves Rodrigues A. |
| |
|
Effects on quality prescription of a prospective interventional study based on a restrictive antibiotic policy
|
| Jover F., Cuadrado J.M., Sánchez V., Ortiz de la Tabla V., Gonzalez M., Martinez R., López-Calleja E., Martin C. |
| |
|
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomised controlled trials
|
| Vidal L., Gafter-Gvili A., Borok S., Fraser A., Leibovici L., Paul M. |
| |
|
Efficacy and safety of caspofungin in solid organ transplant recipients
|
| Petrovic J., Ngai A., Bradshaw S., Williams-Diaz A., Taylor A., Sable C., Kartsonis N. |
| |
|
Efficacy and safety of colistin
|
| Levcovich A., Lischenski Y., Leon P., Lev S., Hazzan R., Chowers M., Bishara J., Leibovici L., Paul M. |
| |
|
Efficacy and safety of gatifloxacin for chronic prostatitis (NIH category II or IIIa) in Korea
|
| Lee S., Kim M., Kim C., Shim B., Kim D., Han C., Ha Y., Cho Y. |
| |
|
Efficacy and safety of tenofovir, abacavir and efavirenz in treatment-naïve patients: 48-week results (The ABATE Trial)
|
| Leon A., Pich J., Ferrer E., Murillas J., García I., Segura F., Vidal F., Gutierrez F., Podzamczer D., Miro J.M. |
| |
|
Efficacy and safety of Uro-vaxom treatment for patients with recurrent cystitis: open multicentre study
|
| Ha U-S., Chang S-G.C., Park H.K., Yoon S.J., Cho Y-H. |
| |
|
Efficacy and safety of voriconazole in real-life setting in Belgium: results from the Voribel-1 trial
|
| Jacobs F., Selleslag D., Aoun M., Sonnet A., Gadisseur A., Damas P., Laterre P., Van Der Meeren O. |
| |
|
Efficacy and tolerance of linezolid-rifampicin combination prolonged oral therapy for bone and joint infections
|
| Senneville E., Legout L., Lemaire X., Dehecq C., Beltrand E., Loiez C., Migaud H., Yazdanpanah Y. |
| |
|
Efficacy of a commercial multiplex herpes viruses PCR in the viral diagnosis of different clinical samples
|
| Reina J., Ruiz de Gopegui E., Mena A., Macia M. |
| |
|
Efficacy of gentamicin for 5 days plus doxycycline for eight weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis
|
| Hasanjani Roushan M.R., Soleimani Amiri M.J., Janmohammadi N., Soleimani Amiri S. |
| |
|
Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection
|
| Murillo O., Euba G., Domenech A., Garcia A., Tubau F., Cabellos C., Gudiol F., Ariza J. |
| |
|
Efficacy of linezolid in the treatment of biofilm-associated infection using a rabbit model of methicillin-resistant Staphylococcus aureus catheter biofilm
|
| Ghannoum M., Long L., Kim H., Rotondo V., Cirino A., Sheehan D. |
| |
|
Efficacy of long-term co-trimoxazole in Q fever during pregnancy
|
| Carcopino X., Raoult D., Boubli L., Stein A. |
| |
|
Efficacy of micafungin in patients with deep, invasive Candida infections
|
| Ullmann A.J., De Waele J., Betts R., Rotstein C., Nucci M., Kovanda L., Wu C., Buell D., Diekmann H., Koblinger S., Cornely O.A. |
| |
|
Efficacy of oritavancin in a mouse model of Streptococcus pneumoniae pneumonia
|
| Lehoux D., McKay G., Fadhil I., Laquerre K., Malouin M., Ostiguy V., Moeck G., Parr Jr T. |
| |
|
Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus
|
| Hegde S., Reyes N., Skinner R., Difuntorum S. |
| |
|
Efficacy of tigecycline versus levofloxacin in patients hospitalised with community-acquired pneumonia: analysis of risk factors
|
| Dartois N., Dukart G., Cooper C., Castaing N., Gandjini I., Sarkozy on behalf of the 308 D., Groups 313 Study |
| |
|
Efficacy of tigecycline (TGC) compared with levofloxacin (LEV) for treating Streptococcus pneumoniae bacteraemia in patients (pts) hospitalised with community-acquired pneumonia (CAP)
|
| Dartois N., Dukart G., Cooper C.A., Castaing N., Gandjini on behalf of the 308 H., Groups 313 Study |
| |
|
Efficacy of voriconazole versus anidulafungin alone and in combination in a guinea pig model of invasive pulmonary aspergillosis
|
| Kirkpatrick W.R., Najvar L.K., Bocanegra R., Vallor A.C., Olivo M.C., Molina D., Graybill J.R., Patterson T.F. |
| |
|
Efficiency of RNA isolation from respiratory samples using the NucliSENS miniMAG and easyMAG extraction procedures
|
| Manji R., Zhang F., Ginocchio C. |
| |
|
Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa
|
| Hirakata Y., Kondo A., Hoshino K., Miyazaki T., Kurihara S., Izumikawa K., Seki M., Yanagihara K., Miyazaki Y., Kamihira S., Kohno S. |
| |
|
EF-Tu, a novel phosphorylcholine-containing protein involved in the interaction of chronic infectious Pseudomonas aeruginosa isolates with the airway epithelial cells
|
| Barbier M., García L., Oliver A., Goldberg J.B., Albertí S. |
| |
|
Elimination of Staphylococcus aureus nasal carriage in healthcare workers of a burn centre: effect on incidence of S. aureus of burn wound colonisation
|
| Kooistra-Smid A.M.D., Nieuwenhuis M.K., Zanten van E., Hiddingh J., Beerthuizen G.I.J.M., Vogels W.H.M., Belkum van A., Verbrugh H.A. |
| |
|
Elimination of false negativity of internal amplification control in PCR assay
|
| Sayan M., Yumuk Z., Çelebi S., Willke A. |
| |
|
Emergence and dissemination of metallo-b-lactamases producing strains in Europe: report from the SENTRY Antimicrobial Surveillance Program
|
| Deshpande L., Sader H., Fritsche T., Jones R. |
| |
|
Emergence of Klebsiella pneumoniae with an AmpC and blaSHV-11 in a Belgian hospital
|
| Vanwynsberghe T., Boel A., Cartuyvels R., Raymaekers M., De Beenhouwer H. |
| |
|
Emergence of Salmonella spp. isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates
|
| Rotimi V.O., Jamal W.Y., Pal T., Sonnevend A., Dimitrov T.S., Albert M.J. |
| |
|
Emergence of a new epidemic Clostridium difficile strain (ribotype 017) resistant to newer fluoroquinolones in Poland
|
| Pituch H., Wultanska D., Obuch-Woszczatynski P., Nurzynska G., van Leeuwen W., Meisel-Mikolajczyk F., Luczak M., van Belkum A. |
| |
|
Emergence of carbepenem-resistant Acinetobacter baumannii in a Bulgarian university hospital
|
| Dobrewski R., van der Reijden T.J.K., van Strijen E., Keuleyan E., Hitkova H., Savov E., Lesseva M., van den Broek P.J., Dijkshoorn L. |
| |
|
Emergence of EMRSA-15 in a university hospital, Canary Islands
|
| Montesinos I., Delgado T., Castro B., Cuervo M., Lecuona M., Ramos M., Sierra A. |
| |
|
Emergence of fluoroquinolone resistance in the murine model of tuberculosis
|
| Aubry A., Chauffour A., Truffot-Pernot C., Jarlier V., Veziris N. |
| |
|
Emergence of linezolid resistance of S. epidermidis in a critical care unit
|
| Martínez L., Treviño M., Cortizo S., Peñalver M., García-Zabarte M., Pardo F., Regueiro B. |
| |
|
Emergence of linezolid-resistant Enterococcus faecalis in Spain and rapid characterisation by real-time PCR
|
| Cercenado E., Marin M., Cuevas O., Bouza E. |
| |
|
Emergence of linezolid-resistant methicillin-resistant Staphylococcus aureus in Japan
|
| Hanaki H., Yanagisawa C., Hososaka Y., Ishibashi K., Yamamoto S., Imamura Y., Taniwaki S., Nakae T., Sunakawa K. |
| |
|
Emergence of metallo-b-lactamase-producing Proteus mirabilis in the community setting
|
| Poulou A., Markou F., Kolliou V., Iliopoulou H., Tsakris A., Rozi P. |
| |
|
Emergence of optochin resistance among Streptococcus pneumoniae in Portugal
|
| Aguiar S., Frias M.J., Santos L., Melo-Cristino J., Ramirez M. |
| |
|
Emergence of PCR-ribotype 027 Clostridium difficile-associated disease, Northern France, 2006
|
| Coignard B., Barbut F., Blanckaert K., Thiolet J., Carbonne A., Astagneau P., Petit J., Popoff M., Desenclos J. |
| |
|
Emergence of PER-1 extended-spectrum b-lactamase-producing Acinetobacter baumannii clinical isolate in Bulgaria
|
| Strateva T., Ouzounova-Raykova V., Todorova A., Mitov I. |
| |
|
Emergence of resistance to new antimicrobials detected among Shigella isolates in Finland
|
| Haukka K., Siitonen A. |
| |
|
Emergence of worldwide epidemic clones of vancomycin-resistant Enterococcus faecium in a Northern Spain hospital
|
| Romo M., Tomita H., Ike Y., Martínez-Martínez L., Francia M. |
| |
|
Emerging broad-spectrum b-lactamases in Escherichia coli: latest ESBLs and carbapenemases
|
| Poirel L. |
| |
|
Emerging colimycin resistance in Gram-negative strains isolated from intensive care unit patients
|
| Kontopidou F.V., Antoniadou A., Poulakou G., Papadomichelakis E.D., Galani I., Armaganidis A., Giamarellou H. |
| |
|
Emerging pathogens and host species barriers
|
| Kuiken T. |
| |
|
Emerging viral diseases: fighting an uphill battle
|
| Lam S.K. |
| |
|
Empirical antifungal therapy in febrile neutropenic patients – systematic review
|
| Goldberg E., Gafter-Gvili A., Paul M., Robenshtok E., Vidal L., Leibovici L. |
| |
|
Empirical treatment of Candidaemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
|
| Guinea J., Peláez T., Torres-Narbona M., Muñoz P., Alcalá L., Bouza E. |
| |
|
Endemic serogroup W135 meningococcal meningitis possibly originated from 2000 and 2001 Hajj epidemics: a prospective study for the aetiology of childhood acute bacterial meningitis in Turkey
|
| Ceyhan M., Yildirim I., Balmer P., Borrow R., Secmeer G., Dikici B., Turgut M., Kurt N., Aydogan A., Ecevit C., Anlar Y., Gulumser O., Tanir G., Salman N., Gurler N., Aydin N., Hacimustafaoglu M., Celebi S., Coskun Y., Alhan E., Celik U., Camcioglu Y. |
| |
|
Enhanced surveillance of MRSA bacteraemia in English hospitals: comparison of risk factors in patients with community onset bacteraemia with cases whose onset was in hospital
|
| Pearson A., Wagner K., Murray M., Painter M., Giltrow J., Fleming M. |
| |
|
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin
|
| Kiyota H., Onodera S. |
| |
|
Enhancement of yeast susceptibility to antifungals
|
| Subik J., Cernicka J., Kozovska Z., Valachovic M., Hapala I., Hajos G. |
| |
|
Enrollment of women in HIV clinical trials in Rwanda
|
| Ackerson L., Abalikumwe F., Goble M., Horsburgh R. |
| |
|
Enteric fever due to Brucella melitensis: a case report
|
| Erbay A., Bodur H., Akinci E., Bastug A., Cevik M.A. |
| |
|
Enterococcal endocarditis: a comparison of patients with native and prosthetic valve endocarditis and analysis of risk factors of mortality
|
| Fernández-Guerrero M., Goyenechea A., Salinas A., Fernández Roblas R., Fraile J., De Górgolas M. |
| |
|
Enterovirus meningitis in south west Greece: clinical manifestations and CSF laboratory findings
|
| Frantzidou F., Agelatou A., Dumaidi K., Kaleyias J., Papa A., Antoniadis A., Spiliopoulou A. |
| |
|
Environmental contamination in the rooms of MRSA-colonised patients
|
| von Baum H., Raychevska F., Möricke A. |
| |
|
Environmental decontamination of an intensive care unit to control outbreaks of multidrug-resistant Gram-negative rods using hydrogen peroxide vapour
|
| Schouten M., Otter J., van Zanten A., Houmes-Zielman G., Nohlmans-Paulssen M. |
| |
|
Enzyme-linked Immunospot testing to assess the cell-mediated immune response to anthrax vaccine precipitated booster vaccination
|
| Hepburn M., Eyles J., Paterson G., Dyson E., Simpson A. |
| |
|
Epidemiologic characteristics of Clostridium difficile infection in a tertiary hospital in Korea
|
| Shin B-M., Yoo H.M., Kuak E-Y., Yoo S.J. |
| |
|
Epidemiologic study of paediatric bacterial meningitis in Greece (1998–2006)
|
| Lebessi E., Papadimitriou M., Paleologou N., Kallergi K., Niniou I., Malliou K., Antonaki G., Ioannidou S., Foustoukou M. |
| |
|
Epidemiologic surveillance of nosocomial infections in the intensive care unit: role of risk factors, emerging pathogens and cross-transmission
|
| Agodi A., Barchitta M., Cipresso R., Giaquinta L., Romeo M., Denaro C. |
| |
|
Epidemiological and clinical features of a hepatitis A outbreak among adults in Albania
|
| Harxhi A., Pano K., Kraja D., Bino S., Kakarriqi E., Ulqinaku D. |
| |
|
Epidemiological and clinical investigation of Gram-negative anaerobic infections in Greece
|
| Katsandri A., Avlamis A., Legakis N.J., Petrikkos G.L., Pantazatou A., Papaparaskevas for The Hellenic Study Group for Gram-Negative Anaerobic Bacteria* J. |
| |
|
Epidemiological aspects of Borrelia spielmanii from Germany with special respect to its genetic heterogeneity
|
| Fingerle V., Schulte-Spechtel U., Ruzic-Sabljic E., Strle F., Leonhard S., Hoffmann H., Weber K., Pfister K., Wilske B. |
| |
|
Epidemiological characteristics of nosocomial blood infections at a clinical centre, Belgrade, Serbia in 2005
|
| Jovanovic B., Mioljevic V., Jovanovic S., Mazic N., Palibrk I. |
| |
|
Epidemiological considerations about hydatid disease in Constanta county, Romania
|
| Dumitru I., Rugina S., Dumitru E. |
| |
|
Epidemiological investigation of Clostridium difficile associated diarrhoea in a tertiary care hospital
|
| Mela V., Dimarogona K., Pantazatou A., Rebelou D., Katsandri A., Papaparaskevas J., Avlamis A. |
| |
|
Epidemiological study of infections caused by extended-spectrum b-lactamase producing Escherichia coli and Klebsiella spp. in a tertiary care hospital in Badajoz, Spain (2003–2005)
|
| Garduño E., Galán-Ladero M.A., Muñoz-Lozano M.T., Sánchez-González M., Blanco-Palenciano J. |
| |
|
Epidemiological surveillance and characterisation of TEM-, SHV-, and CTX-M-type ESBLs in Russian nosocomial strains of Enterobacteriaceae using real-time PCR and melting-curve analysis techniques
|
| Stepanova M., Nikulin A., Sukhorukova M., Edelstein M. |
| |
|
Epidemiological, clinical and serological features of human leptospirosis in Bulgaria in 2005
|
| Taseva E., Christova I., Gladnishka T. |
| |
|
Epidemiology and antibiotic resistance of bacterial isolates from patients with bacteraemia in an intensive care unit
|
| Ikonomopoulou E., Georgakoloulos P., Michail P., Paratiras S., Stavropoulou G., Verra C., Dondou V., Regli A. |
| |
|
Epidemiology and diagnosis of epidemic and avian influenza in Australia
|
| Baleriola C., Stelzer S., Escott R., Kirkland P., Robertson P., Rawlinson W. |
| |
|
Epidemiology and genetic features of CTX-M-15-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005
|
| Damjanova I., Tóth Á., Hajbel-Vékony G., Pászti J., Berta J., Füzi M. |
| |
|
Epidemiology and genotypes of plasmid-mediated AmpC b-lactamase produced by clinical isolates of Klebsiella pneumoniae in Korea
|
| Song W., Lee C.H., Kim J.S., Kim H.S., Uh Y., Lee J., Lee K. |
| |
|
Epidemiology and mechanism of resistance of an outbreak of multidrug-resistant Acinetobacter baumannii at in a Lebanese hospital
|
| Di Popolo A., Khan A.U., Daoud Z., Bagattini M., Afif C., Triassi M., Hakimé N.I., Zarrilli R. |
| |
|
Epidemiology and molecular characterisation of clinical isolates of Escherichia coli producing extended-spectrum b-lactamases from Rome, Italy
|
| Carattoli A., Garcia A., Varesi P., Fortini D., Gerardi S., Penni A., Mancini C., Giordano A. |
| |
|
Epidemiology and outcome of primary and secondary community-acquired bacteraemia in adult patients
|
| Ortega M., Almela M., Martínez J., Marco F., Soriano A., López J., Sánchez M., Muñoz A., Mensa J. |
| |
|
Epidemiology of Candidakrusei and Candida inconspicua infections in haematology-oncology ward
|
| Sikora M., Swoboda-Kopec E., Stelmach E., Interewicz B., Domaszewska A., Majewska A., Olszewski W., Luczak M. |
| |
|
Epidemiology of Haemophilus influenzae serotype A from 2000–2005, an emerging pathogen in Northern Canada and Alaska
|
| Hennessy T., Bruce M., Deeks S., Cottle T., Palacios C., Case C., Hemsley C., Lovgren M., Sobol I., Corriveau A., Larke B., Debyle C., Harker-Jones M., Hurlburt D., Peters H., Parkinson A. |
| |
|
Epidemiology of candidaemia and antifungal susceptibility patterns in a Turkish university hospital
|
| Serin Senger S., Demirbilek M., Kurt Azap O., Timurkaynak F., Arslan H. |
| |
|
Epidemiology of ESBL-positive Enterobacteriacae in Copenhagen, Denmark
|
| Fjeldsøe-Nielsen H., Friis-Møller A., Schrøder Hansen D., Frimodt-Møller N., Schønning K. |
| |
|
Epidemiology of evolution and antibiotic resistance profile of Acinetobacter baumannii and Pseudomonas aeruginosa in a Greek tertiary care hospital
|
| Protonotariou E., Vitti D., Tsivitanidou M., Sofianou D. |
| |
|
Epidemiology of extended-spectrum b-lactamase-producing Enterobacteriaceae in Belgium: preliminary results of a national multicentre survey in 2006
|
| Glupczynski Y., Berhin C., Rodriguez-Villalobos H., Struelens M., Jans on behalf of the Belgian Infection Control Society B. |
| |
|
Epidemiology of Haemophylus influenzae and meningococcal invasive diseases in a Spanish hospital (1987–2006)
|
| Blanco R., Unzaga M., Ezpeleta C., Alava J., Guerediaga I., Amezua B., Cabezas V., Cisterna R. |
| |
|
Epidemiology of hospital-acquired Klebsiella pneumoniae producing CTX-M b-lactamases in Slovenia
|
| Me[scaron]ko Meglic K., Koren S., Palepou M.F.I., Karisik E., Livermore D.M., Andlovic A., Jeverica S., Kri[zcaron]an-Hergouth V., Mueller-Premru M., Seme K., Woodford on behalf of the Slovenian ESBL Study Group N. |
| |
|
Epidemiology of human leptospirosis in Malaysia
|
| Fairuz A., Abdul Rani B., Ayu M., Hishamshah I. |
| |
|
Epidemiology of infections caused by extended-spectrum b-lactamases producing Escherichia coli for a three-year period
|
| Gallardo M.M., García M.V., Rodríguez R., Ropero F., Granados E., Gutierrez A., Pinedo A. |
| |
|
Epidemiology of invasive Streptococcus pneumoniae in Taiwan, 2001–2003
|
| Chen C-J., Huang Y-C., Su L-H., Lin T-Y. |
| |
|
Epidemiology of invasive Streptococcus pyogenes infections in Germany
|
| Wahl R., Lütticken R., Stanzel S., van der Linden M., Reinert R. |
| |
|
Epidemiology of invasive pneumococcal infections
|
| Brueggemann A. |
| |
|
Epidemiology of MRSA colonisation in a university hospital and a cardiosurgical hospital in Hessen, Germany
|
| Knaust A., Madlener K., Tschernych N., Barekzai J., Eikmann T., Herr C. |
| |
|
Epidemiology of multiresistant Enterococcus faecalis and Enterococcus faecium collected during 2004 to 2006 in a Lisbon hospital
|
| Pires R., Pereira M., Rodrigues P., Carvalho S., Ferreira T., Mato R. |
| |
|
Epidemiology of urinary pathogens in adults during 2005–2006
|
| Apostolidou I., Zoumberi M., Papaefstathiou K., Koloka E., Kouppari G. |
| |
|
Epidemiology trends of candidaemia in an adult intensive care unit in a teaching hospital
|
| Garbino J., Rohner P., Alencar Nobre V., Vernaz N., Garzoni C., Romand J-A. |
| |
|
EpiScanGIS: a geographical information system for laboratory surveillance of meningococcal disease in Germany
|
| Reinhardt M., Elias J., Albert J., Frosch M., Vogel U., Harmsen D. |
| |
|
Eradication of induced mouse fibrosarcoma with combination of verotoxin1 and monophosphoryl lipid A
|
| Hosain Zadegan H., Sattari M., Mohammad Hasan Z., Allameh A. |
| |
|
ESAC II hospital care subproject 2005–2007: improving quality indicators of hospital antibiotic prescribing within standardised data, longitudinal study
|
| Ansari F., Goossens H., Davey on behalf of the ESAC II HC Subproject Working Group P. |
| |
|
ESAC II Hospital Care Subproject 2005–2007: patterns of antibiotic use in relation to diagnoses in 19 European hospitals in 2006, Point Prevalence Study
|
| Erntell M., Ansari F., Goossens H., Davey for the ESAC II HC Subproject Working Group P. |
| |
|
ESBL evolution in Italy: rapid regional spread of a multidrug-resistant Klebsiella pneumoniae strain producing CTX-M-15
|
| Mugnaioli C., Manso E., Rossolini G. |
| |
|
ESBL-producing Enterobacteriaceae from non-human sources (poultry and swine) in Portugal
|
| Machado E., Coque T., Cantón R., Baquero F., Silva J., Sousa J.C., Peixe L. |
| |
|
ESBL-producing Enterobecteriaceae and in vitro evaluation of tigecycline
|
| Chinou E., Davlouros P., Georgouli M., Skoutelli E., Kamagiani A., Golemati P. |
| |
|
Essential oil composition and antibacterial effects of Ziziphora clinopodioides
|
| Chitsaz M., Barton M., Bazargan M., Kamalinejad M. |
| |
|
Estimation of the incubation period for pandemic influenza during 1918–19
|
| Nishiura H. |
| |
|
Ethanol lock therapy: preliminary trial results and future research agenda
|
| Broom J. |
| |
|
Europe surveillance initiative profiling the activity of telavancin against streptococci by specimen source from 2004 to 2005
|
| Draghi D., Benton B., Jones M., Krause K., Thornsberry C., Sahm D. |
| |
|
Europe surveillance initiative profiling the anti-enterococcal activity of telavancin by specimen source from 2004 to 2005
|
| Sahm D., Draghi D., Benton B., Jones M., Krause K., Thornsberry C. |
| |
|
Europe surveillance initiative profiling the anti-staphylococcal activity of telavancin by specimen source from 2004 to 2005
|
| Draghi D., Benton B., Jones M., Krause K., Thornsberry C., Sahm D. |
| |
|
European Antimicrobial Susceptibility Surveillance in Animals (EASSA): Results (2002/2003) for enteric bacteria from healthy cattle, pigs and chickens from 8 countries
|
| Simjee S., de Jong A., McConville M., Bywater R., Chaton-Schaffner M., Deroover E., Klein U., Shryock T., Simmons R., Smets K., Stewart F., Thomas V., Valle M., Marion H. |
| |
|
European consensus on malaria chemoprophylaxis
|
| Hatz C. |
| |
|
European surveillance of ICU-acquired infections (HELICS-ICU), 2004–2005: ICU-acquired pneumonia
|
| Suetens C., Savey A., Palomar M., Hiesmayr M., Lepape A., Morales I., Gastmeier P., Schmit J.C., Valinteliene R., Fabry for the HELICS-ICU Data Centre J., Health Scientific Institute of Public, Brussels |
| |
|
European surveillance of surgical site infections (HELICS-SSI), 2004–2005
|
| Wilson J., Suetens C., Ramboer I., Fabry for the HELICS-SSI working group J. |
| |
|
European survey on the use of antibacterial prophylaxis in neutropenic cancer patients: a joint project of the EORTC and the EBMT
|
| Akan H., Marchetti O., Cordonnier C., Calandra for the Infectious Diseases Group of the European Organization for Research T., Cancer Treatment of |
| |
|
Evaluation by molecular tools of Brucella persistence in soil
|
| Koncan R., del Campo R., Bianchi S., Amendola A., Mazzariol A., Cantón R., Baquero F., Cornaglia G. |
| |
|
Evaluation of Haemophilus influenzae isolates from children with respiratory tract infections
|
| Makri A., Papavasileiou K., Panagiotaki E., Papavasileiou H., Varzakakos I., Voyatzi A. |
| |
|
Evaluation of Helicobacter pylori stool antigen test for the detection of H. pylori infection in paediatric patients
|
| Gonzalez Mediero G., Ramos J.M., García J.I., Otero Varela I., Del Blanco T., Sanchez Conde J.A. |
| |
|
Evaluation of 4 chromogenic media for detection and identification of clinically relevant yeasts
|
| Ieven M., Wouters Z., Vercauteren E., Goossens H. |
| |
|
Evaluation of a competitive quantitative RT-PCR-ELISA system for quantification of HIV-1 RNA in plasma: comparison with COBAS Amplicor HIV-1 monitor test
|
| Amel jamehdar S., Sabahi F., Forouzandeh M., Haji Abdolbaghi M., Kazemnejad A., Mahboudi F., Edalat R., Ravanshad M. |
| |
|
Evaluation of a direct cefoxitin disc diffusion test for the presumptive identification of MRSA from clinical specimens
|
| Fuller J., Lui B., Rosmus L., Johnson J., Rennie R. |
| |
|
Evaluation of a fully automated Multiplexed Bead assay for assessment of Epstein-Barr virus immunologic status
|
| Baccard M., Seigneurin J.M. |
| |
|
Evaluation of a new automated urine cell analyser (Sysmex UF-1000i) for bacteriological urinalysis
|
| von Wulffen H. |
| |
|
Evaluation of a new chromogenic medium SaSelect for identification of Staphylococcus aureus
|
| Daurel C., Leclercq R. |
| |
|
Evaluation of a new combined hepatitis C antigen/antibody assay for routine HCV testing of patient samples
|
| Vermeersch P., Van Meensel B., Van Ranst M., Lagrou K. |
| |
|
Evaluation of a new commercial real-time PCR for the detection of Aspergillus spp. in serum and respiratory samples
|
| Hayette M.P., Meex C., Boreux R., Huynen P., Melin P., De Mol P. |
| |
|
Evaluation of a new LightCycler approach for detection of diarrhoeagenic Escherichia coli
|
| Ljung R., Eysturskard J., Olesen B., Bruun B., Hansen D.S. |
| |
|
Evaluation of a new rapid method for microbial growth analysis and antimicrobial susceptibility test in human biological fluids
|
| Tessari A., Parisi S.G., Cavallaro A. |
| |
|
Evaluation of a new ultra-rapid hand drier in relation to hand hygiene
|
| Snelling A.M., Saville T., Stevens D.G., Beggs C.B. |
| |
|
Evaluation of a new version of the ``RT-TB'' triplex real-time PCR assay for the rapid diagnosis of Mycobacterium tuberculosis in clinical samples
|
| Sougakoff W., Millot G., Truffot-Pernot C., Veziris N., Brossier F., Jarlier V. |
| |
|
Evaluation of a rapid automated assay for the isolation of Mycobacterium tuberculosis DNA directly from clinical samples, using magnetic particles
|
| Lysén J., Høidal Berthelsen H.K., Espelund M., Jeansson S., Mengshoel A.T., Refseth U.H. |
| |
|
Evaluation of a rapid molecular dipstick assay for the direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens
|
| Eigner U., Holfelder M., Wild U., Bender C., Kirstahler M., Turnwald A., Witte W., Weizenegger M., Fahr A. |
| |
|
Evaluation of a rapid new stool antigen test for diagnosis of Helicobacter pylori infection in adult patients
|
| Krausse R., Müller G., Doniec M. |
| |
|
Evaluation of a rapid test panel, the API Strep 20, the BD Phoenix and VITEK 2 automated instruments, and Raman spectroscopy for species identification of Enterococci
|
| Top J., Scholtes M., Maquelin K., Willems R., Bonten M., Wolfhagen M., Hegge R., Asbroek M., Bruins M., Leverstein-van Hall M. |
| |
|
Evaluation of a real-time PCR assay and an multiplex-reverse hybridisation system for the detection of methicillin-resistant Staphylococcus aureus
|
| Ieven M., Michiels M., Jansens H., Goossens H. |
| |
|
Evaluation of a real-time RT-PCR assay for the diagnosis of measles virus infections during a measles outbreak in Greece
|
| Kokotas S., Giannaki M., Horefti E., Sgouras D., Logothetis M., Panagiotopoulos P., Georgakopoulou T., Kansouzidou A., Theodoridou M., Pangalis A., Mentis A. |
| |
|
Evaluation of an automated chemiluminescent immunoassay for the detection of anti-rubella virus IgM antibodies
|
| Pustowoit B., Liebert U.G. |
| |
|
Evaluation of an automated sample preparation system (MDx) in combination with affigene CMV trender
|
| Abbate I., Finnstrom N., Garbuglia A., Solmone M., Selvaggini S., Bennici E., Neri S., Brega C., Capobianchi M. |
| |
|
Evaluation of antibacterial activity and biofilm formation in Klebsiellapneumoniae in contact with essential oil and alcoholic extract of cumin seed (Cuminum cyminum)
|
| Derakhshan S., Sattari M., Bigdeli M. |
| |
|
Evaluation of cefoxitin disks to detect methicillin-resistant coagulase negative staphylococci
|
| Mouton J.W., Bohne M.T., Klaassen C.H., Horrevorts A.M., de Valk H.A., Voss A. |
| |
|
Evaluation of cellular immune response against purified antigen 85 in patients with tuberculosis
|
| Nikokar I., Makvandi M., Huygen K. |
| |
|
Evaluation of clinical dosage of gatifloxacin for respiratory tract infections in elderly patients
|
| Yoneyama H., Niki Y., Matsushima T. |
| |
|
Evaluation of continuous ambulatory peritoneal dialysis-related peritonitis attacks in Ankara
|
| Ozturk R., Bulut C., Yilmaz G.R., Parpucu H., Irmak H., Kinikli S., Duranay M., Demiroz A.P. |
| |
|
Evaluation of daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations
|
| Rose W., Rybak M., Leonard S., Sakoulas G., Kaatz G., Zervos M., Sheth A., Carpenter C. |
| |
|
Evaluation of Etests for determining tigecycline MICs by BSAC methodology
|
| Hope R., Mushtaq S., Livermore D. |
| |
|
Evaluation of expected clinical success of tigecycline and other commonly used antimicrobials for empiric treatment of complicated skin and skin structure infections in Germany, Spain and the United States
|
| Mallick R., Fritsche T., Jones R., Kuznik A., Stilwell M., Sader H. |
| |
|
Evaluation of five commercial screening assays and two commercial immunoblots for the serological diagnosis of Lyme borreliosis
|
| Matthys C., Petrens E., Padalko E., Lagrou K., Van Renterghem L. |
| |
|
Evaluation of five commercially available rapid ESBL detection methods in a routine clinical microbiology laboratory
|
| Lo-Ten-Foe J., Hendriks-Franssen M., Buiting A. |
| |
|
Evaluation of fluorescence in situ hybridisation for the identification of clinically relevant Candida species
|
| Poppert S., Lakner A., Bartel M., Essig A. |
| |
|
Evaluation of in vitro activity of tigecycline and ten comparators against methicillin-resistant Staphylococcus aureus from 34 countries: TEST Program 2004–2006
|
| Badal R., Bouchillon S., Hackel M., Johnson J., Hoban D., Johnson B., Dowzicky M. |
| |
|
Evaluation of InfluA&B Respi-Strip for the rapid detection of influenza A and B viruses in respiratory samples
|
| Degallaix S., Denorme L., Lefèvre O., Labrune V., Laurent T., Leclipteux T., Mertens P. |
| |
|
Evaluation of isavuconazole (BAL8557/BAL4815) Etest compared to broth microdilution antifungal susceptibility testing against quality control strains and fluconazole-susceptible clinical Candida isolates
|
| Heep M., Grover P., Brown N.P., Sahm D., Jones M.E. |
| |
|
Evaluation of malaria status and immune response to Plasmodium falciparum MSP-2
|
| Khosravi A., Hommel M. |
| |
|
Evaluation of metallo-b-lactamase producing Klebsiella pneumoniae epidemiology in a Greek hospital (2004–2006)
|
| Moraitou H., Kentrou N., Galani I., Tsagarakis N., Makarona M., Gioga A., Kanavaki S. |
| |
|
Evaluation of MLVA and spa-typing as a rapid method for studying relationships of human and bovine Staphylococcus aureus
|
| Ikawaty R., Verhoef J., Fluit A.C. |
| |
|
Evaluation of moxifloxacin and levofloxacin against S. pyogenes in various animal models
|
| Endermann R., Ehlert K. |
| |
|
Evaluation of NAD+-dependent DNA ligase of mycobacteria as a potential target for antibiotics
|
| Rychta E., Korycka-Machala M., Brzostek A., Sayer H., Rumijowska-Galewicz A., Bowater R., Dziadek J. |
| |
|
Evaluation of nosocomial infections in the hospitalised patients of intensive care unit of a university hospital, Kashan, Iran
|
| Khorshidi A. |
| |
|
Evaluation of partial 16S rRNA gene sequencing for identification of clinical isolates of non-tuberculous mycobacteria in a routine mycobacterial laboratory
|
| Insa R., Marín M., Ruiz Serrano M.J., del Rosal M., Goyanes M.J., García de Viedma D., Bouza E. |
| |
|
Evaluation of partial rpoB and 16S rDNA sequencing for identification of Enterococcal species and the comparison to phenotypic methods
|
| Haase G., Lütticken R., Weber-Heynemann J., Ramminger I., Mellmann A., Harmsen D. |
| |
|
Evaluation of PlateliaTM Dengue NS1 Antigen assay for early diagnosis of acute dengue infection
|
| Tabouret M., Salanon C., Sarfati P. |
| |
|
Evaluation of PlateliaTM Lyme IgM and PlateliaTM Lyme IgG assays for Lyme borreliosis diagnosis
|
| Jaulhac B., De Martino S., Tabouret M. |
| |
|
Evaluation of real-time PCR assays, based in molecular beacon technology, for detection and quantification of Mycobacterium tuberculosis DNA
|
| Houhoula D.P., Siatelis A., Legakis N.J., Tsakris A., Papaparaskevas J. |
| |
|
Evaluation of real-time PCR based assays for the detection and quantitation of CMV DNA
|
| Rudolph M., Willert B., Grewing T., Fuhrmann J. |
| |
|
Evaluation of reported percutaneous/mucocutaneous injuries in a tertiary care hospital
|
| Kanyilmaz D., Erbay A., Avci N., Oztas D., Bodur H. |
| |
|
Evaluation of Rubella IgG and IgM assays on the new Vidia® instrument
|
| Medici M.C., Albonetti V., Martinelli M., Chezzi C., Dettori G. |
| |
|
Evaluation of seroconversion to measles vaccine in vaccinated infants in Ibadan, Nigeria
|
| Akinloye O.M., Oyedele O., Akinloye O., Adu F. |
| |
|
Evaluation of serum bactericidal activity specific for Neisseria meningitidis serogroup A and B: effect of immunisation with N. meningitidis serogroup A polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent vaccine candidate
|
| Adibi Motlagh B., Siadat S.D., Behzadiyannejad Q., Tabaraiee B., Ahmadi H., Najar Peerayeh S., Nourouzian Shamasbi D., Nejati M., Hedayati M.H., Moshiri A. |
| |
|
Evaluation of the 3M Rapid Detect Staph aureus: an in vitro diagnostic device for direct detection of Staphylococcus aureus nasal colonisation
|
| Bode L.G.M., Hendriks Y., Vos M.C., Verbrugh H.A., Kluytmans J.A.J.W., Morse D.J., Wood M.E. |
| |
|
Evaluation of the Abbott M2000 sp/rt real-time PCR on Chlamydia trachomatis and Neisseria gonorrhoeae using urine samples, and comparison with the Roche Cobas Amplicor Ctr/Ngo PCR assays
|
| Luijt D., Schirm J. |
| |
|
Evaluation of the antibody responses induced by the 2006–2007 influenza vaccine
|
| Chan Y.-J., Hwang S.-J., Lin J.-C., Tsai C.-H., Liu C.-Y., Lee S.-D., Ho D.M., Lee C.-H. |
| |
|
Evaluation of the BACT/ALERT 3D system for testing susceptibility of Mycobacterium tuberculosis to first-line antituberculosis agents: comparison with BacTec MGIT 960 and Lowenstein-Jensen proportion method
|
| Guney C., Suel A., Karagoz T., Yorulmaz Y. |
| |
|
Evaluation of the BacT/Alert PZA test for susceptibility testing of Mycobacteriumtuberculosis to pyrazinamide in comparison with BacTec 460TB
|
| Garrigó M., Moreno C., Aragon L., Coll P. |
| |
|
Evaluation of the efficacy of disinfectants used in hospital aseptic dispensing against Bacillus spores
|
| Mehmi M., Smith J., Lambert P. |
| |
|
Evaluation of the IDI-MRSA assay for detection of methicillin-resistant Staphylococcus aureus from clinical specimens
|
| Lucke K., Hombach M., Pfyffer G.E. |
| |
|
Evaluation of the in vitro activity of levofloxacin and moxifloxacin tested against Stenotrophomonas maltophilia: can moxifloxacin activity be predicted by levofloxacin MIC results?
|
| Gales A., Jones R., Janechek M., Sader H. |
| |
|
Evaluation of the increase rate of MRSA detection using enrichment
|
| Curry A., Walsh M., Cahill N., Collins E., Knowles S. |
| |
|
Evaluation of the knowledge of hospital cleaning staff about prevention of nosocomial infections
|
| Tasbakan M., Calik S., Pullukcu H., Sipahi O., Yamazhan T., Ulusoy S. |
| |
|
Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of Gram-positive cocci and Gram-negative bacilli from positive blood cultures
|
| Pietzcker T., Wellinghausen N., Poppert S., Belak S., Fieser N., Bartel M., Essig A. |
| |
|
Evaluation of the new Vidia® toxoplasmosis IgG and IgM assays in women of childbearing age
|
| Zufferey J., Di Mito C., Auckenthaler R. |
| |
|
Evaluation of the new VITEK 2 NH identification card
|
| Valenza G., Ruoff C., Vogel U., Frosch M., Abele-Horn M. |
| |
|
Evaluation of the role of Chlamydia trachomatis in chronic prostatic infection
|
| Ouzounova-Raykova V., Mizgova G., Ouzounova E., Mitov I. |
| |
|
Evaluation of the VITEK® 2 system for testing of Gram-negative bacilli directly from BacT/Alert Fan blood cultures
|
| Ullberg M., Bergström J. |
| |
|
Evaluation of three commercial assays for the detection of Giardia and Cryptosporidium organisms in stool specimens
|
| Dauby N., Moens C., Mohamed S., Van den Wijngaert S., Vandenberg O., Dediste A. |
| |
|
Evaluation of three media for the cryopreservation of peripheral blood mononuclear cells for ELISPOT
|
| Maier C., Bigler S., Bodmer T. |
| |
|
Evaluation of tigecycline in vitro activity against panresistant Klebsiellapneumoniae clinical isolates
|
| Stylianakis A., Koutsoukou A., Tsiplakou S., Garavella V., Taxtatzis M., Merianos I. |
| |
|
Evaluation of two new tests for the detection of Helicobacter pylori in stool specimens
|
| Blanco S., Lacoma A., Forne M., Prat C., Latorre I., Cuesta M., Viver J., Ausina V., Dominguez J. |
| |
|
Evaluation of various carbon sources on conidia production among clinical isolated moulds
|
| Santanirand P., Thanavanitnam S., Chongtrakool P., Angkananukool K. |
| |
|
Evaluation of various fluoroquinolones against S. pneumoniae with 1st step mutations of parC
|
| Chin J., Rybak M., Kaatz G. |
| |
|
Evaluation the cefoxitin 30 mG disk diffusion method for detection of methicillin-resistance in selected Staphylococcus aureus isolates
|
| Lara M., Batista N., Laich F., Méndez-Álvarez S. |
| |
|
Evidence for the role of Haemophilus influenzae in the pathogenesis of recurrent tonsillitis
|
| Skoulakis C., Tigiroglou E., Malli E., Klapsa D., Papadakis C., Petinaki E. |
| |
|
Evidence of Epstein-Barr and cytomegalovirus co-infection in ulcerative colitis
|
| Pape M., Mandraveli K., Papadopoulou D., Sidiropoulos I., Koliouskas D., Alexiou-Daniel S. |
| |
|
Evolution of H. influenzae resistance in a chest diseases hospital, for the period 2001–2006
|
| Tsagarakis N., Gioga A., Makarona M., Moraitou H., Kentrou N., Panagi M., Pefanis A., Damianidou S., Kanavaki S. |
| |
|
Evolution of antimicrobial susceptibility of Campylobacter jejuni strains isolated from hospitalised children in Athens, Greece
|
| Papavasileiou H., Papavasileiou K., Chatzipanagiotou S., Makri A., Andrianopoulou I., Voyatzi A. |
| |
|
Evolution of bla genes from SHV family
|
| Mendonça N., Caniça M. |
| |
|
Evolution of susceptibility of non-typhi Salmonella in Spanish hospital: six years of surveillance
|
| Quiles M.I., Garcia-Bujalance S., Mingorance J., Gomez-Gil R., Gutierrez A. |
| |
|
Ex vivo profiling of cytokines/chemokines in patients with tuberculosis and latent tuberculosis infection
|
| Bodmer T., Grandgirard D., Bigler S., Daubenberger C., Leib S. |
| |
|
Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis
|
| Basu S., Pathak Suschil, Banerjee A., Pathak Shresh, Bhattacharyya A., Yang Z., Talarico S., Kundu M., Basu J. |
| |
|
Existence of Bartonella henselae reservoir in Poland
|
| Chmielewski T., Marczak R., Sochon E., Podsiadly E., Tylewska-Wierzbanowska S. |
| |
|
Exogenous ventilator associated pneumonia incidence in a medical-surgical intensive care unit: a four-year surveillance
|
| Lecuona M., Lorente L., Miguel M., Castro B., Campos S., Pedroso Y., Sierra A. |
| |
|
Experiences and results from the surveillance programme of resistance in feed, food and animals in Norway (NORM-VET) 2000–2005
|
| Norström M., Tharaldsen H., Sunde M. |
| |
|
Experimental studies with T. pallidum Nichols strain – Efficacy of treatment in late infection
|
| Magalhães Sant`Ana A.C., Rocha G., Poiares da Silva J. |
| |
|
Expert rules for aminoglycosides, macrolides and lincosamides
|
| Leclercq R. |
| |
|
Explosive emergence of CTX-M-15 extended-spectrum b-lactamase in Enterobacteriaceae in Kuwait
|
| Poirel L., Rotimi V., Bernabeu S., Jamal W., Nordmann P. |
| |
|
Expression of human serum albumin–L7/L12 (Brucella abortus ribosomal protein) fusion protein in Saccharomyces cerevisiae
|
| Pakzad I., Rezaee A., Rasaee M., Hosseini A., Kasemnejad A., Tabaraiee B. |
| |
|
Expression of icaA and icaD genes by quantitative real-time PCR in correlation to biofilm synthesis among methicillin-resistant coagulase-negative staphylococci
|
| Foka A., Chini V., Petinaki E., Dimitracopoulos G., Spiliopoulou I. |
| |
|
Expression of IgA-specific endopeptidases from Neisseria meningitidis in E. coli
|
| Khamiankou V., Kazeeva T., Shevelev A. |
| |
|
Expression of phagocyte Fcg receptors during anti-tuberculous treatment
|
| Escobar M.A., Garcia-Egido A.A., Gomez-Soto F.M., Fernandez F.J., Puerto J.L., Ruiz P., Rivera C., Gomez F. |
| |
|
Expression of phagocyte Fcg receptors in HIV infected patients with tuberculosis
|
| Escobar M.A., Garcia-Egido A.A., Bernal J.A., Fernandez F.J., Rosety M., Ruiz P., Rivera C., Gomez F. |
| |
|
Extended evalution of the NucliSens easyMAG sytem (BioMérieux) for automated extraction of microbiological DNA/RNA
|
| Beuselinck K., Verschueren E., Van Eldere J. |
| |
|
Extended-spectrum b-lactamase among non-typhoidic Salmonella in paediatric unit of Algerian hospital
|
| Ouar-Korichi M., Assaous F., Gilly L., Paul G., Rahal K. |
| |
|
Extended-spectrum b-lactamase producing Enterobacteriaceae in a Swiss university hospital: molecular characterisation and susceptibility to ertapenem
|
| Bruderer T., Widmer A.F., Flury M., Oezcan S., Jutzi M., Frei R. |
| |
|
Extended-spectrum b-lactamases and plasmid-mediated AmpC enzymes among Enterobactercloacae strains isolated from cardiovascular prosthetic devices associated infections
|
| Cernat R., Balotescu C., Lazar V., Banu O., Ivanescu D., Bucur M. |
| |
|
Extending structure-activity-relationship studies of bioactive natural products by novel iminonitroso cycloaddition chemistry
|
| Miller M., Moellmann U., Li F., Yang B., Zoellner T., Gebhardt P., Dahse H., Miller P. |
| |
|
Extensively drug-resistant tuberculosis (XDR TB) in Athens
|
| Karabela S., Nikolaou S., Kouseris I., Makrigiannis N., Kanavaki S. |
| |
|
Extracellular and intracellular activities of quinupristin-dalfopristin (Synercid) against Staphylococcus aureus, with different resistant phenotypes (MSSA, MRSA, VISA)
|
| Baudoux P., Glupczynski Y., Tulkens P., Van Bambeke F. |
| |
|
Extraction, purification and detoxification of Brucella abortus lipopolysaccharide and biological activity evaluation
|
| Pakzad I., Rezaee A., Rasaee M., Hosseini A., Kasemnejad A., Bahman T., Saied R. |
| |
|
Extrapulmonary mycobacteria isolations
|
| Karabela S., Nikolaou S., Raftopoulou A., Anagnostou S., Kouseris I., Makrigiannis N., Koletou M., Kanavaki S. |
| |
|
Extrapulmonary tuberculosis in central Tunisia: a review of 114 cases
|
| Kaabia N., Bellezreg F., Khalifa M., ben Jazia E., Braham A., Bahri F., Letaief A. |
| |
